FAQ
Intro
Survey
Topics
Please select the name from the list.
If the name is not there, means it is not connected with a GND -ID?

GND: 132178281


Click on a term to reduce result list Information symbol The result list below will be reduced to the selected search terms. The terms are generated from the titles, abstracts and STW thesaurus of publications by the respective author.

b

Match by:
Sort by:

The information on the author is retrieved from: Entity Facts (by DNB = German National Library data service), DBPedia and Wikidata

Claude Évin


Alternative spellings:
Claude Evin

B: 1949
Biblio: Franz. Politiker
The image of the author or topic
Source: Wikimedia Commons

Information about the license status of integrated media files (e.g. pictures or videos) can usually be called up by clicking on the Wikimedia Commons URL above.

Profession

  • Politiker
  • External links

  • Gemeinsame Normdatei (GND) im Katalog der Deutschen Nationalbibliothek
  • Bibliothèque nationale de France
  • Wikipedia (English)
  • NACO Authority File
  • Virtual International Authority File (VIAF)
  • Wikidata
  • International Standard Name Identifier (ISNI)


  • Claude Évin (born 29 June 1949) is a French politician and lawyer. He was first elected in 1978. Prior to becoming a Member of Parliament, Claude Évin was the deputy mayor of Saint-Nazaire, a post he held until 1989. In his lengthy career, he held a variety of positions including Vice President of the National Assembly (1986–87); Minister for Health (1988–91) and Minister for Social Affairs (1988–91). As Minister for Health, he proposed the French alcohol and tobacco policy law, now known as Loi Évin, to the parliament (Law 91-32 of 10 January 1991). Since being replaced as an MP for Loire-Atlantique by Marie-Odile Bouillé, he has moved to chairing the French Hospital Federation (FHF). Évin is also notable for mandating the drug company Roussel Uclaf to resume the distribution of mifepristone, an abortifactant, two days after the company's board voted 16–4 to discontinue its distribution due to concerns of the image of the company's majority-owner. This was regarding a negative public image related to the popular anti-abortion sentiments of France in the late 1980s. He stated "I could not permit the abortion debate to deprive women of a product that represents medical progress. From the moment government approval for the drug was granted, RU-486 became the moral property of women, not just the property of a drug company." (Source: DBPedia)

    Publishing years

    1
      1996
    1
      1983

    Series

    1. Avis et rapports du Conseil Économique et Social (1)
    2. Préparation du (1)